Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection-Reference-Cited by-同舟云学术

Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection

Published:2020-02-28 Issue:2 Volume:24 Page:215-232
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Hirschfeld Marc,Rücker Gerta,Weiß Daniela,Berner Kai,Ritter Andrea,Jäger Markus,Erbes Thalia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40291-020-00453-y.pdf

Reference152 articles.

1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59. https://doi.org/10.1016/S0140-6736(17)32154-2.

2. Sharma R. Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from Global Burden of Disease Study 2016. Breast Cancer. 2019;26(4):428–45.

3. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019;11:151–64.

4. Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast Cancer Screening for Women at Average Risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.

5. Tabar L, Yen AM, Wu WY, Chen SL, Chiu SY, Fann JC, et al. Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J. 2015;21(1):13–20.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensors Based on Molecularly Imprinted Polymers in the Field of Cancer Biomarker Detection: A Review;Nanomaterials;2024-08-19

2. Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers;Biosensors and Bioelectronics;2024-08

3. ECM1 and ANXA1 in urinary extracellular vesicles serve as biomarkers for breast cancer;Frontiers in Oncology;2024-07-08

4. Exosomal microRNAs: impact on cancer detection, treatment, and monitoring;Clinical and Translational Oncology;2024-07-06

5. Self‐Sustaining Triboelectric Nanosensors for Real‐Time Urine Analysis in Smart Toilets;Small;2024-06-21